The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
US healthcare starts transforming–what are the opportunities? A ‘ripple’ of a Tunstall partnership, NHS CCGs forcing disabled into care homes, and tenders posted in Scotland and Wales. From the art...
Currently voice control is attracting much of the smart-home spotlight but it is products will also increasingly rely on video and data analytics, sound recognition and artificial intelligence to simp...
How can the health-care industry create incentives and provide technology to get more Americans to live healthier lifestyles? That was the key question at the Connected Health Summit this week in San...
An industry report by Parks Associates has estimated global mobile data revenue will rise from $368 billion in 2015 to $630 billion by 2020. The internationally-recognised consulting firm claims th...
